ACSL4 and metabolic dysfunction-associated steatotic liver disease: Furthermore, the present study demonstrated that ECH significantly up-regulated the levels of Nrf2, HMOX-1, GPX4, and SLC7A11 and down-regulated the expression level of ACSL4 in the liver tissues of MASLD model mice.